Trial intelligence / Profile preview

Comparative study of racemic ketamine versus S-ketamine on cerebral blood flow, volume and metabolism

2008-008597-31Phase 2Active

Sponsor
Skåne University Hospital
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ketamine and esketamine in Shock (2 arms), sponsored by Skåne University Hospital. Primary endpoints: Cerebral blood flow and blood volume comparison and ASL-MRI application evaluation. Started Apr 2009; status: active.

02

Drugs

ketamineesketamine
03

Conditions

Shock

Beyond the preview

Go deeper on 2008-008597-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008597-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call